Bipolar At Risk Trial II (BART II)

  • Research type

    Research Study

  • Full title

    Cognitive behavioural therapy in comparison to treatment as usual in young adults at high risk of developing bipolar disorder (Bipolar At Risk): A randomised controlled trial to investigate the efficacy of a treatment approach targeted at key appraisal change

  • IRAS ID

    316335

  • Contact name

    Sophie Parker

  • Contact email

    Sophie.Parker@gmmh.nhs.uk

  • Sponsor organisation

    Greater Manchester Mental Health NHS Foundation Trust

  • ISRCTN Number

    ISRCTN13363197

  • Duration of Study in the UK

    3 years, 11 months, 31 days

  • Research summary

    Our trial will be a multicentre, raterblinded randomised control trial (RCT) with 2 parallel arms. It will compare a psychological intervention (Cognitive Behavioural Therapy for Bipolar At Risk (CBT_BAR)) + (treatment condition (TAU)) to TAU alone (control condition).

    For those who are randomsied to receive the CBT_BAR, up to 26 individual weekly therapy sessions of up to 60 mins will be offered.

    Outcome and mediational variables will be collected at baseline, 17-weeks (during treatment window capturing Structured Clinical Interview for Axis 1 Disorders (SCID-5) with Positive Symptom Ratings (PSR's), Hypomanic Positive Predictions Inventory (HAPPI), Internal States Scale (ISS), and the Behaviour Checklist (BC)), 27-weeks (after therapy cessation), and at 52-weeks.

    Participants will be randomised to one of two trial arms. Randomisation will be independent and concealed, using permuted stratified blocks, where site (5-levels) and BAR group (3-levels) are the stratification factors. It will be conducted via a web-based system conducted within York Clinical Trials Unit.

    The research objective is to recruit 338 participants across 5 NHS sites (representing 4 NHS commissioning regions in England: Greater Manchester, Lancashire, Sheffield, Birmingham, and Norfolk & Suffolk), who meet the Bipolar At Risk (BAR) criteria.

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    22/NW/0355

  • Date of REC Opinion

    13 Dec 2022

  • REC opinion

    Further Information Favourable Opinion